Henry Schein Inc. (NASDAQ:HSIC) has been assigned an average rating of “Hold” from the eleven brokerages that are presently covering the company. Seven investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $171.52.

A number of research analysts recently issued reports on the stock. Leerink Swann reissued a “hold” rating on shares of Henry Schein in a research note on Thursday, November 3rd. JPMorgan Chase & Co. reissued a “hold” rating and issued a $163.00 price objective on shares of Henry Schein in a research note on Thursday, November 3rd. Zacks Investment Research raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Friday, November 4th. Robert W. Baird cut shares of Henry Schein from an “outperform” rating to a “neutral” rating and decreased their price objective for the company from $176.00 to $164.00 in a research note on Friday, October 14th. Finally, Goldman Sachs Group Inc. raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective on the stock in a research note on Tuesday, October 11th.

Shares of Henry Schein (NASDAQ:HSIC) opened at 157.83 on Thursday. The stock has a 50 day moving average price of $156.38 and a 200 day moving average price of $167.39. Henry Schein has a 1-year low of $142.64 and a 1-year high of $183.00. The company has a market capitalization of $12.70 billion, a price-to-earnings ratio of 26.21 and a beta of 1.09.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Wednesday, November 2nd. The company reported $1.68 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.65 by $0.03. Henry Schein had a net margin of 4.40% and a return on equity of 18.15%. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.88 billion. During the same period last year, the firm earned $1.55 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. Analysts forecast that Henry Schein will post $6.58 earnings per share for the current year.

In other news, EVP Mark E. Mlotek sold 2,417 shares of Henry Schein stock in a transaction on Thursday, November 3rd. The shares were sold at an average price of $155.19, for a total transaction of $375,094.23. Following the transaction, the executive vice president now owns 40,456 shares in the company, valued at $6,278,366.64. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Paul Brons sold 3,381 shares of Henry Schein stock in a transaction on Monday, August 29th. The stock was sold at an average price of $164.03, for a total transaction of $554,585.43. Following the transaction, the director now owns 13,715 shares in the company, valued at approximately $2,249,671.45. The disclosure for this sale can be found here. Insiders own 1.27% of the company’s stock.

Institutional investors have recently modified their holdings of the company. Neville Rodie & Shaw Inc. raised its position in Henry Schein by 9.6% in the second quarter. Neville Rodie & Shaw Inc. now owns 43,660 shares of the company’s stock valued at $7,719,000 after buying an additional 3,820 shares during the last quarter. Creative Planning raised its position in Henry Schein by 20.5% in the second quarter. Creative Planning now owns 6,526 shares of the company’s stock valued at $1,154,000 after buying an additional 1,110 shares during the last quarter. Chevy Chase Trust Holdings Inc. raised its position in Henry Schein by 4.0% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 223,907 shares of the company’s stock valued at $39,587,000 after buying an additional 8,624 shares during the last quarter. Exxonmobil Investment Management Inc. TX raised its position in Henry Schein by 6.5% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 21,243 shares of the company’s stock valued at $3,756,000 after buying an additional 1,292 shares during the last quarter. Finally, Arizona State Retirement System raised its position in Henry Schein by 1.1% in the first quarter. Arizona State Retirement System now owns 62,500 shares of the company’s stock valued at $10,789,000 after buying an additional 700 shares during the last quarter. Institutional investors own 93.43% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

5 Day Chart for NASDAQ:HSIC

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.